# Trial to Evaluate the Effect of Plantago Ovata Husk in the Remission of Metabolic Syndrome in Children and Adolescents

> **NCT00748787** · PHASE2 · TERMINATED · sponsor: **Rottapharm Spain** · enrollment: 19 (actual)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DRUG:** Ispaghula husk
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00748787
- **Lead sponsor:** Rottapharm Spain
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-10
- **Primary completion:** 2009-11
- **Final completion:** 2010-06
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** It was very difficult to fulfill the inclusion criteria, therefore the expected time of inclusion was delayed so much time.
- **Last updated:** 2011-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00748787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00748787, "Trial to Evaluate the Effect of Plantago Ovata Husk in the Remission of Metabolic Syndrome in Children and Adolescents". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00748787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*